PATENT CLAIM ANALYSIS

Application Number: 16040245
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-06
Patent Classification: ["544", "293000"]

Abstract:
The present invention relates to inhibitors of ROCK1 and ROCK2 and methods of modulating the pharmacokinetic and/or pharmacodynamic properties of such compounds. Also provided are methods of inhibiting ROCK1 and or ROCK2 that are useful for the treatment of disease.

Claim (Index 28):
The method of  claim 27 , wherein the disease is fibrosis.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 95.0
- Lexical Diversity: 1.4
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13715644', '11887218', '14581746', '15809460', '14431936']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7801330072563436
- 35 USC 102 Novelty (BERT): 0.5369886560635705
- Combined Prediction Score: 0.7558185721370663
- Mean Citation Score: 334.4715040000001
- Max Citation Score: 365.19812
- Similarity Product: 259.36586409076216

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test